Literature DB >> 17908713

Should gonadotropin releasing hormone analogue be administered to prevent premature ovarian failure in young women with systemic lupus erythematosus on cyclophosphamide therapy?

Rajiv Sinha1, Janis M Dionne.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17908713     DOI： 10.1136/adc.2007.131334

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN： 0003-9888            Impact factor:   3.791


× No keyword cloud information.
  2 in total

1.  Nonmalignant diseases and treatments associated with primary ovarian failure: an expanded role for fertility preservation.

Authors:  Jennifer Hirshfeld-Cytron; Clarisa Gracia; Teresa K Woodruff
Journal:  J Womens Health (Larchmt)       Date:  2011-08-09       Impact factor: 2.681

2.  Randomized, double-blind, dose-escalation trial of triptorelin for ovary protection in childhood-onset systemic lupus erythematosus.

Authors:  Hermine I Brunner; Clovis A Silva; Andreas Reiff; Gloria C Higgins; Lisa Imundo; Calvin B Williams; Carol A Wallace; Nadia E Aikawa; Shannen Nelson; Marisa S Klein-Gitelman; Susan R Rose
Journal:  Arthritis Rheumatol       Date:  2015-05       Impact factor: 10.995
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.